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Abstract
Background: Assisted reproductive techniques (ART) are associated with a higher risk of tetralogy of Fallot (TOF)
and multiple pregnancies may be associated with a higher risk of congenital anomalies. We assessed the extent to
which the association between ART and risk of TOF may be mediated by the higher risk of multiple pregnancies
associated with ART.
Methods: We conducted a case–control study using population-based data from the Paris Registry of Congenital
Malformations for the period 1987–2009 and a cohort study of congenital heart defects (EPICARD). The study population
included 395 cases of TOF and 4104 malformed controls with no known associations with ART. The analysis was based
on a path-analysis model using a counterfactual approach, which allows decomposition of the total effect of ART into an
indirect effect (that mediated by the association between ART and multiple pregnancies) and a direct effect.
Results: ART (all methods combined) were associated with a 2.6-fold higher odds of TOF after adjustment for maternal
and paternal characteristics and year of birth (adjusted OR 2.6, 95% CI, 1.5-4.5). Most (79%) of the effect associated with
ART was a direct effect (i.e., not mediated by multiple pregnancies), whereas 21% of the effect of ART was due to its
association with multiple pregnancies (i.e., the indirect effect). In vitro fertilization with intracytoplasmic sperm injection
was associated with a 3.5-fold higher odds of TOF (adjusted OR 3.5, 95% CI, 1.1-11.2); 11% of this effect was mediated
through the association of ICSI with multiple pregnancies.
Conclusions: By far, most of the higher risk of TOF associated with ART is a direct effect and only a small proportion of
the effect may be mediated by multiple pregnancies.
Keywords: Multiple pregnancies, Reproductive techniques, Assisted, Heart defects, Congenital, Tetralogy of Fallot,
Epidemiology
Background
Assisted reproductive techniques (ART) are methods used
to achieve pregnancy in case of female and/or male infertil-
ity. ART are known to be associated with a higher risk of
multiple pregnancies [1,2], mostly due to superovulation or
transfer of two or more eggs or embryos. An overall higher
risk of congenital malformations in fetuses conceived fol-
lowing ART has been reported in several studies [3-10]
using different study populations and designs and methods
of analysis and at times inconsistent results, particularly for
specific anomalies [6].
Few studies have assessed specifically the risk of con-
genital heart defects (CHD) associated with ART
[6,11-15]. These studies have found an increased risk of
30-50% (Odds ratios ~1.3-1.5) of the overall risk of CHD,
which varied across categories of CHD and methods of
ART [12-15]. In particular, a recent study assessing the
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risk for four individual CHD, (Transposition of Great
Arteries, Hypoplastic Left Heart, Coarctation of Aorta
and Tetralogy of Fallot (TOF)) [15] found a specifically
higher risk of TOF associated with ART. In contrast, the
authors found no statistically significant associations with
the other three defects examined and the effect sizes (odds
ratios) were close to the null value (i.e., close to one).
Even if multiple pregnancies may be independently as-
sociated with a higher risk of congenital anomalies [16,17]
and this may be specifically the case for CHD, relatively
little information exist on the specific association between
multiple pregnancies and CHD [18-20], particularly for in-
dividual defects [21].
Given: i) the previous finding of the specific association
between ART and TOF [15], ii) the known association be-
tween ART and multiple pregnancies, and iii) the possible
association of the latter with the risk of congenital anom-
alies, the objective of the present study was to assess the
impact of multiple pregnancies in the association between
TOF and ART using a path-analysis model.
Material and methods
Data sources
Two sources of data were used for this study: 1) the Paris
Registry of Congenital Malformations and 2) the EPICARD
study (Epidemiological study on the outcomes for congeni-
tal heart diseases). These two sources of data are briefly de-
scribed below.
The Paris Registry of Congenital Malformations
Since 1981, the Paris Registry of Congenital Malformations
registers all cases of birth defects and chromosomal anom-
alies among live-births, still-births (≥ 22 weeks of gestation)
and termination of pregnancy for fetal anomaly. The
Registry covers the population of women who live in
Greater Paris area (Paris and its surrounding suburb)
and deliver or have a termination of pregnancy for fetal
anomaly in a Parisian maternity unit. The annual num-
ber of deliveries in our population is about 38,000.
The Paris Registry is a member of the European network
of registries of congenital malformations (EUROCAT) and
of the International clearinghouse for birth defects surveil-
lance and research [22-25]. The Registry follows the
EUROCAT methodology and quality of data is routinely
monitored by both EUROCAT and the National commit-
tee of registries in France. Review of procedures regarding
confidentiality of data is overseen by both the National
committee of registries and the National committee of in-
formatics and freedom. Data are based on medical records
and are collected from several sources including maternity
units, neonatology wards, cytogenetic and pathology services.
In the present study, data from the Registry corre-
sponded to the period 1987 to 2009 as the first case of a
malformation with exposure to IVF occurred in 1987
and 2009 was the last year for which data were available
at the time of the study.
EPICARD
The EPICARD study [26] is an ongoing prospective co-
hort study of all children with a CHD born to women liv-
ing in the Greater Paris area (Paris and its surrounding
suburbs) between 2005 and 2008 regardless of place of de-
livery (total number of births 317538). The principal ob-
jectives of the study are to use population-based data from
a large cohort of patients with CHD to: i) estimate total
and live birth prevalence, pre- and postnatal diagnosis of
CHD; ii) assess medical and surgical management of chil-
dren with CHD, iii) evaluate neonatal mortality and mor-
bidity and neuro-developmental outcomes of children
with CHD; and iv) identify the factors associated with
their health outcomes, especially the role of events during
the neonatal period and of the initial medical and surgical
management. All cases (live births, terminations of preg-
nancy for fetal anomaly, fetal deaths) diagnosed in the pre-
natal period or up to one year of age in the birth cohorts
between May 1st 2005 and April 30th 2008 were eligible
for inclusion. The total number of cases included in the
study was 2867, including 2348 newborns (82%), 466 ter-
minations of pregnancy for fetal anomaly (16.2%) and 53
fetal deaths (1.8%). Diagnoses were confirmed in special-
ized paediatric cardiology departments and for the major-
ity of terminations of pregnancy for fetal anomaly and
fetal deaths by fetopathologist examination; for others in
which a pathology exam could not be done (26%) the
diagnoses were confirmed by consensus by a paediatric
cardiologist and a specialist in echocardiography based on
results of prenatal echocardiography examination.
Methods
We conducted a case–control study with malformed con-
trols. Cases were fetuses/newborns with tetralogy of Fallot
(TOF). Two sources of data, the EPICARD study and the
Paris Registry of Congenital Malformations (1987–2009),
were used for inclusion of cases. The data source for the
malformed controls was the Paris Registry data (1987–
2009, i.e., the same period as for the cases). Malformed
controls were isolated cases of single malformations (i.e.
those that were not associated with chromosomal or any
other anomalies / genetic syndromes) and for which no
evidence of an association with ART was found in the lit-
erature. As recommended by Hook [27], we selected a
wide spectrum of heterogeneous birth defects as controls
in order to decrease the risk of selection bias due to
shared etiologic factors between cases and controls. The
malformations in the control group comprised club-foot,
angioma, skin abnormalities, polydactyly, syndactyly and
congenital hip dislocation.
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Exposure to ART included the following categories: in-
ductors of ovulation only (IO), in vitro fertilization (IVF)
only and IVF with intracytoplasmic sperm injection (IVF +
ICSI). Exposure to ART was assessed as: i) a binary variable
(ART yes/no), ii) a variable in four categories (no ART, IO,
IVF only, IVF + ICSI) and iii) a variable combining IVF
only and IVF with ICSI (IVF +/− ICSI) in a single category.
Potential confounding factors considered were maternal
characteristics (age, occupation and geographic origin),
paternal age and year of birth (or termination of preg-
nancy for fetal anomaly). Although their exact relations to
the risk for specific CHD are not well known, these factors
are associated with both exposure to ART and prevalence
of birth defects in general [28,29]. Maternal occupation
was coded in five categories (professional, intermediate,
administrative/public service, other and none) following
the French National Institute of Statistics and Economic
Studies (INSEE) classification. Geographic origin was
coded in four categories: French, North African, Sub-
Saharan African and other countries.
Statistical analysis
We conducted a logistic regression analysis using a path-
analysis model [30,31] to decompose the total effect associ-
ated with ART into an indirect effect (that mediated by the
association between ART and multiple pregnancies) and a
direct effect (Figure 1). The path-analysis model uses a
counterfactual (“what if”) approach and its basis may be
formulated conceptually as the response to the following
question: “What would be the risk of TOF associated with
ART if ART-conceived fetuses had the same probability of
multiple pregnancies as spontaneously-conceived fetuses?”
In case of a binary exposure, two estimates of the direct
and indirect effects are possible. The first one is based on
the answer to the counterfactual question above. The
second estimate is based on the alternative question:
“What would be the risk of TOF associated with ART if
spontaneously-conceived fetuses had the same probability
of multiple pregnancies as ART-conceived fetuses?” These
two estimates are not necessarily the same, although they
are usually very similar. One suggestion is to report the
average of these two estimates for assessing the direct vs.
indirect (mediated) effect of the exposure. In our study
the two set of estimates were very similar and we reported
the estimates that corresponded to the first counterfactual
question noted above.
Analyses were conducted for all cases of TOF and for
“isolated” cases of TOF (i.e. excluding cases associated with
chromosomal anomalies or anomalies of other systems).
The statistical significance level was set at α = 0.05 and
all tests were two-sided. Analyses were done with Stata
11 software (Statacorp, Texas, USA) and add-on models
developed by Buis [30].
Ethics
No specific ethical approval was needed for this particular
analysis. The French National Committee of Informatics
and Freedom (CNIL) has authorised the surveillance and
research activities of the Registry using anonymous data
and has approved the EPICARD study.
Results
Study population
The study population included 404 cases of TOF, among
which 97.8% (n = 395) had complete data on ART. Associ-
ated chromosomal anomalies were found in 20.3% (n = 80)
of the cases of TOF. The control group included 4250 fe-
tuses, among whom 96.6% (n = 4104) fetuses had complete
data on ART. The control group included 35.0% (n = 1
436) with congenital hip dislocation, 20.0% (n = 824) with
club-foot, 19.1% (n = 782) with polydactyly, 12.6% (n = 517)
with angioma, 9.3% (n = 38) with skin abnormality, and
4.0% (n = 164) with syndactyly.
Table 1 shows the comparison of the characteristics of
cases of TOF and controls. Cases and controls were differ-
ent for most characteristics. In particular, mothers of cases
of TOF were older than mothers of controls (31.7 vs.
30.4 years, p < 0.001), and were more likely to be from
North Africa (18.1 vs. 10.4%, p < 0.001). Stillbirths and ter-
minations of pregnancy for fetal anomaly were more likely
to occur for cases of TOF than controls (4.5 vs. 0.2% and
29.0% vs. 0.3% respectively, p < 0.001). Cases of TOF were
more likely to have been conceived following ART (all
methods combined) than controls (6.6 vs. 3.5%, p = 0.002).
Exposure to the different methods of ART also differed
significantly between cases and controls. In particular,
1.3% of cases of TOF were conceived following IVF + ICSI
vs. 0.3% of controls (p < 0.001). The study population in-
cluded 329 cases of TOF and 2670 controls conceived
spontaneously. The odds of TOF was 1.5-fold higher
(OR= 1.5, 95% CI 0.8-2.7) in twins vs. singleton pregnan-
cies conceived spontaneously; however, this association
was not statistically significant (p = 0.17).
Table 2 shows the comparison of the study population
characteristics according to exposure to ART (all methods
combined). Mothers who had conceived following ART
Figure 1 Decomposition of the total effect of ART on the risk of
TOF into a direct effect and an indirect effect mediated through
multiple pregnancies.
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Table 1 Associations between predictor variables and case/control status
Characteristics TOF (N=404) Controls (N=4 250) p
n* %§ n* %§
Mother Age (years)
Mean (SD) 31.7 (5.6) 30.4 (5.2) <0.001
Median (p25-p75) 31.5 (28 – 36) 30 (27 – 34)
<20 3 0.8 59 1.4 <0.001
20 – 29 146 36.5 1,809 42.8
30 – 34 126 31.5 1,434 33.9
35 – 39 91 22.8 722 17.1
≥ 40 34 8.5 203 4.8
Geographic origin
France 200 50.4 2,412 57.9 <0.001
North Africa 72 18.1 433 10.4
Subsaharan Africa 39 9.8 550 13.2
Other 86 21.7 770 18.5
Occupation
None 113 30.9 1,083 26.3 0.096
Professional 84 23.0 997 24.2
Intermediate 64 17.5 856 20.8
Administrative/public service 67 18.3 852 20.7
Other 38 10.4 330 8.0
Father Age (years)
Mean (SD) 35.0 (6.6) 33.9 (6.6) 0.006
Median (p25-p75) 34 (30 – 39) 33 (29 – 38)
<20 1 0.3 5 0.1 0.014
20 – 29 59 19.5 890 25.8
30 – 34 94 31.1 1,198 34.7
35 – 39 79 26.2 734 21.3
≥ 40 69 22.9 734 21.3
Geographic origin
France 179 49.2 2,325 58.6 <0.001
North Africa 66 18.1 416 10.5
Subsaharan Africa 38 10.4 529 13.3
Other 81 22.3 700 17.6
Occupation
None 24 7.6 281 7.4 0.014
Professional 110 34.6 1,474 38.6
Intermediate 44 13.8 566 14.8
Administrative/public service 28 8.8 479 12.5
Other 112 35.2 1,020 26.7
Pregnancy Outcome
Still-births 18 4.5 7 0.2 <0.001
Live-births 269 66.6 4,231 99.6
Pregnancy terminations 117 29.0 12 0.3
Art None 369 93.4 3,959 96.5 0.004
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were older than mothers who had conceived spontaneously
(33.0 vs. 30.4 years, p < 0.001), more likely to be of French
origin (72.9 vs. 56.4%, p < 0.001) and in the highest occupa-
tional category “professional” (35.5 vs. 23.6%, p < 0.001).
Multiple births were more likely to occur after ART con-
ception (23.7 vs. 2.9% for twins and 4.6 vs. 0.1% for triplets,
p < 0.001). Still-births also tended to be more likely in the
ARTconceived fetuses (1.8 vs. 0.5%, p = 0.099).
Risk of TOF associated with ART: direct and indirect
(mediated by multiple pregnancies) effects
All cases of TOF
Table 3 summarizes the results of logistic regression ana-
lyses of the association between TOF and ART, including
the path-analysis estimates for the decomposition of the
total effect of ART into its direct and indirect (mediated
by multiple pregnancies) components.
ART (all methods combined) were associated with a
significant increase in the odds of TOF (total effect:
adjusted OR 2.6, 95% CI 1.5 – 4.5). The ART conceived
fetuses would have had a 2.1-higher odds of TOF than
spontaneously conceived fetuses if the risk of multiple
pregnancies were kept constant at the level of spontan-
eously conceived fetuses (direct effect: adjusted OR 2.1,
95% CI 1.2 – 3.7). This estimates suggested in turn that
about 21% of the overall higher odds of TOF associated
with ART was due to the higher probability of multiple
pregnancies following ART.
IO were associated with a 2.1-higher odds of TOF (total
effect: adjusted OR 2.1, 95% CI 1.0 – 4.7). The IO con-
ceived fetuses would have had a 1.8-higher odds of TOF
than spontaneously conceived fetuses if they had the same
risk of multiple pregnancies as for spontaneously conceived
fetuses (direct effect: adjusted OR 1.8, 95% CI 0.9 – 3.9).
Hence, about 19% of the overall higher odds of TOF as-
sociated with IO was due to the higher probability of
multiple pregnancies following IO.
IVF only was associated with a 2.8-higher odds of TOF
(total effect: adjusted OR 2.8, 95% CI 1.2 – 6.7). Approxi-
mately 28% of this overall higher odds of TOF associated
with IVF only was due to the higher probability of multiple
pregnancies following IVF only.
Finally, IVF + ICSI was associated with a 3.5-higher odds
of TOF (total effect: adjusted OR 3.5, 95% CI 1.1 – 11.2).
The IVF + ICSI conceived fetuses would have had a 3.1-
higher odds of TOF than spontaneously conceived fetuses
if they had the same risk of multiple pregnancies as for
spontaneously conceived fetuses (direct effect: adjusted
OR 3.1, 95% CI 0.9 – 10.1). Therefore, about 11% of the
overall higher odds of TOF associated with IVF + ICSI
was due to the higher probability of multiple pregnancies
following IVF + ICSI.
Isolated cases of TOF
Table 4 summarizes the results of logistic regression ana-
lyses of the association between isolated cases of TOF (ex-
cluding cases associated with chromosomal or other
anomalies), including the path-analysis estimates for the
decomposition of the total effect of ART into its direct and
indirect (mediated by multiple pregnancies) components..
The estimates were essentially similar to those found
for all cases combined (i.e. when cases of TOF with and
without associated anomalies were analysed together).
Discussion
Using population-based data on approximately 400 cases
of tetralogy of Fallot (TOF) and 4000 malformed controls,
we assessed the previously reported higher risk of TOF
[15] that may be due (mediated by) multiple pregnancies
in fetuses conceived following assisted reproductive tech-
nologies (ART). We used a path-analysis model based on
a counterfactual approach in order to decompose the total
effect associated with ART into a direct and an indirect ef-
fect (i.e. that due to the association between ART and
multiple pregnancies).
Our results showed that of the overall 2.6-fold higher
odds of TOF in fetuses conceived following ART, 20% was
due to the higher likelihood of multiple pregnancies in fe-
tuses conceived following ART (the “indirect effect”). This
suggests in turn that multiple pregnancies themselves may
be associated with a higher risk of TOF, albeit much less
so than ART. The contribution of multiple pregnancies to
the higher odds of TOF associated with ART (i.e. the in-
direct effect) varied according to the method of ART. Our
estimates suggested that 30% of the total effect of IVF only
was due to multiple pregnancies vs. 11% in the case of
IVF + ICSI. The results were similar for analyses restricted
Table 1 Associations between predictor variables and case/control status (Continued)
IO$ only 11 2.8 77 1.9
IVF£ only 10 2.5 55 1.3
IVF+ICSI¥ 5 1.3 13 0.3
*n represents the number of cases or controls without missing data.
§% calculated with the number of cases or controls without missing data as a denominator.
$Inductors of ovulation.
£In vitro fertilization.
¥IVF with intracytoplasmic sperm injection.
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Table 2 Comparison of the study population characteristics according to exposure to ART (all methods combined)
Variable Exposure to ART p
No Yes
n %§ n %§
Mother Age (years)
Mean (SD) 30.4 (5.2) 33.0 (4.6) <0.001
Median (p25–p75) 30 (27 – 34) 33 (30 – 37)
<20 61 1.4 0 0.0 <0.001
20 – 29 1,874 43.4 39 22.8
30 – 34 1,440 33.4 68 39.8
35 – 39 727 16.9 52 30.4
≥ 40 213 4.9 12 7.0
Geographic origin
France 2,416 56.4 124 72.9 <0.001
North Africa 484 11.3 11 6.5
Subsaharan Africa 573 13.4 9 5.3
Other 808 18.9 26 15.3
Occupation
None 1,134 27.1 24 14.2 <0.001
Professional 988 23.6 60 35.5
Intermediate 851 20.3 43 25.4
Administrative/public service 867 20.7 28 16.6
Other 346 8.3 14 8.3
Father Age (years)
Mean (SD) 33.9 (6.6) 35.0 (5.8) 0.044
Median (p25–p75) 33 (29 – 38) 34 (31 – 38)
<20 6 0.2 0 0.0 <0.001
20 – 29 924 26.1 17 10.8
30 – 34 1,206 34.0 66 42.0
35 – 39 756 21.3 47 29.9
≥ 40 652 27.0 27 17.2
Geographic origin
France 2,327 57.1 118 71.5 0.002
North Africa 463 11.4 11 6.7
Subsaharan Africa 550 13.5 11 6.7
Other 736 18.1 25 15.2
Occupation
None 291 7.5 6 3.7 0.023
Professional 1,454 37.7 80 49.1
Intermediate 573 14.9 25 15.3
Administrative/public service 480 12.4 14 8.6
Other 1,060 27.5 38 23.3
Pregnancy Outcome
Still-births 22 0.5 3 1.8 0.099
Live-births 4,183 96.3 163 95.3
Pregnancy terminations 123 2.8 5 2.9
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to isolated cases of TOF (excluding those associated with
chromosomal or other anomalies).
In order to estimate the risk of congenital malforma-
tions in multiple pregnancies conceived following ART,
previous studies have generally included separate (strati-
fied) analyses for singletons and multiple pregnancies
[8,9,12,13,15,32]. This approach can be informative in
examining the association between ART and the risk of
congenital malformations, in particular regarding the
possible existence of an interaction effect between ART
and multiple pregnancies. However, these studies did
not formally test for statistical significance of any such
interaction and had limited power to detect them if they
indeed existed. In any case, this approach does not allow
a formal estimation of the proportion of the effect of
ART on the risk of congenital malformations that may
be due to multiple pregnancies.
We found that the “direct” effect associated with ART (i.
e. that not mediated by multiple pregnancies) was substan-
tially greater than the indirect effect. This was particularly
so in the case of IVF + ICSI. This finding may provide
clues as to the underlying mechanisms of the association
between ART, particularly for IVF + ICSI, and TOF. The
developmental basis of TOF is complex, incompletely
elucidated and probably multifactorial [33,34]. The im-
plication of genomic imprinting [35-38] and a role for
cardiac neural crest cells in the development of TOF
have been suggested [34,39] but any implication of
ART in these pathways remains to be shown.
Regarding any effects (the indirect effect) due to twinning,
our study was not designed to elucidate what may be the
underlying mechanism of any association between twinning
and risk of TOF (independently of exposure to ART). In
particular, we did not take into account zygosity (or chorio-
nicity), whereas the risk of congenital anomalies in monozy-
gotic twins appears to be higher than that of dizygotic twins
[16,17,20]. Our results suggest however, that any effects due
to twinning per se, whatever its underlying mechanism may
be, are likely to be small. Hence, it is possible that twin preg-
nancies, even in the case of monozygotic twins, are not (or
only to a small extent are) associated with a higher risk of
TOF, whereas for other CHD twinning per se may be a
more important risk factor [16,17,20].
We also did not account for any potential effect of the
“vanishing” twin syndrome on our estimates. Several studies
have found that ART multiple pregnancies in which a twin
vanished had poorer obstetrical and perinatal outcomes
[40-43]. However, to our knowledge, there is no docu-
mented association between the vanishing twin syndrome
and risk of birth defects in general or of CHD in particular.
If indeed such an association exists in the case of TOF, mis-
classification of vanishing twin pregnancies as singletons
would result in an underestimation of the mediating effect
of multiple pregnancies in the association between ART
and risk of TOF.
Our study has certain limitations. Even if the total num-
ber of cases of TOF and controls was fairly large, the
numbers of cases exposed to the different methods of
ART were small and hence confidence interval were fairly
wide reflecting the relative imprecision of our estimates of
ORs particularly for specific techniques of ART.
Although we chose frequent and heterogeneous malfor-
mations for which no association with ART exist in the lit-
erature, bias due to the association between ART and
malformations in the control group cannot be excluded.
In particular, if ART were associated with a higher risk of
one or more of the malformations in the control group,
the consequence would be an underestimation of the true
association between ART and TOF.
Due to a lack of available information in our data, we did
not adjust for certain maternal conditions including preg-
estational or gestational diabetes and obesity, tobacco, alco-
hol and drug consumption. Although these factors may be
associated with risk of birth defects in general, or of CHD
in particular, their associations, if any, with the risk of spe-
cific CHD, including TOF are generally not known.
We also could not adjust for maternal folic acid/multivi-
tamins use that is associated with a lower risk of CHD
[44] and in addition is more frequent in women who con-
ceive following ART [13,45]. Hence, we cannot rule out
residual confounding due to risk (or protective) factors as-
sociated with ART and/or twinning that were not taken
into account.
In addition, our study was not designed to and cannot
disentangle the effects that may be due to infertility of
couples vs. ART or twinning per se [4,9,46]. Some authors
have found that the risk of birth defects is increased in in-
fertile women who conceive spontaneously, which sug-
gests that the underlying infertility problems may explain
part or perhaps all of the association between ART and
Table 2 Comparison of the study population characteristics according to exposure to ART (all methods combined)
(Continued)
Multiplicity
Singletons 2,908 97.0 94 71.8 <0.001
Twins 88 2.9 31 23.7
Triplets 3 0.1 6 4.6
§% calculated with the total of cases or controls without missing data as a denominator.
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Table 3 Decomposition of the total effect of ART on the odds of TOF into a direct effect and indirect effect mediated through multiple pregnancies
Art Total effect Direct effect Indirect effect Estimated size of
the indirect effect
Unadjusted OR* 95% CI Adjusted§ OR* 95% CI Unadjusted OR* 95% CI Adjusted OR* 95% CI Unadjusted OR* 95% CI Adjusted OR* 95% CI
None 1.0 ref. 1.0 ref. 1.0 ref. 1.0 ref. 1.0 ref. 1.0 ref.
All methods
combined
1.9 1.2 – 3.1 2.6 1.5 – 4.5 1.7 1.0 – 2.8 2.1 1.2 – 3.7 1.1 1.0 – 1.4 1.2 1.0 – 1.5 20.9%
IO$ only 1.4 0.7 – 2.9 2.1 1.0 – 4.7 1.3 0.7 – 2.6 1.8 0.9 – 3.9 1.1 1.0 – 1.2 1.2 1.0 – 1.3 19.1%
IVF£ only 2.2 1.0 – 4.7 2.8 1.2 – 6.7 1.8 0.8 – 3.8 2.1 0.9 – 5.2 1.2 0.9 – 1.6 1.3 1.1 – 1.7 27.8%
IVF+ICSI¥ 3.1 1.0 – 10.0 3.5 1.1 – 11.2 2.8 0.9 – 8.9 3.1 0.9 – 10.1 1.1 1.0 – 1.3 1.1 0.9 – 1.4 11.1%
IVF +/- ICSI 2.4 1.3 – 4.6 3.0 1.6 – 5.8 2.1 1.0 – 4.3 2.4 1.2 – 4.6 1.2 0.9 – 1.5 1.3 1.0 – 1.6 22.3%
*Odds ratios (OR) represent the odds of a birth (including live births, stillbirths and pregnancy terminations) with TOF (cases) relative to the odds of a birth with one of the malformed controls (club-foot, angioma, skin
abnormality, polydactyly, syndactyly, and congenital hip dislocation).
§Adjustment was made for maternal age, occupation, geographic origin, paternal age and year of birth.
$Inductors of ovulation.
£In vitro fertilization.
¥IVF with intracytoplasmic sperm injection.
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Table 4 Decomposition of the total effect of ART on the odds of TOF without associated chromosomal anomalies into a direct effect and indirect effect
mediated through multiple pregnancies
Art Total effect Direct effect Indirect effect Estimated size of
the indirect effect
Unadjusted OR* 95% CI Adjusted§ OR* 95% CI Unadjusted OR* 95% CI Adjusted OR* 95% CI Unadjusted OR* 95% CI Adjusted OR* 95% CI
None 1.0 ref. 1.0 ref. 1.0 ref. 1.0 ref. 1.0 ref. 1.0 ref.
All methods
combined
2.3 1.5 – 3.5 3.2 2.1 – 4.7 1.9 1.2 – 3.0 2.5 1.6 – 3.8 1.2 1.0 – 1.4 1.3 1.1 – 1.5 21.5%
IO$ only 1.7 0.9 – 3.1 2.6 1.3 – 5.0 1.5 0.8 – 2.7 2.2 1.2 – 4.0 1.1 1.0 – 1.3 1.2 1.0 – 1.4 18.9%
IVF£ only 2.5 1.1 – 6.1 3.4 1.6 – 7.2 1.9 0.8 – 5.0 2.4 1.2 – 4.8 1.3 1.0 – 1.7 1.4 1.0 – 2.0 29.7%
IVF+ICSI¥ 4.0 1.2 – 13.1 4.4 1.2 – 15.9 3.5 1.1 – 11.5 3.7 1.0 – 13.8 1.1 0.9 – 1.4 1.2 0.9 – 1.5 11.7%
IVF +/- ICSI 2.9 1.6 – 5.4 3.7 2.0 – 7.0 2.3 1.2 – 4.6 2.7 1.5 – 4.9 1.2 1.0 – 1.5 1.4 1.0 – 1.9 23.6%
*Odds ratios (OR) represent the odds of a birth (including live births. stillbirths and pregnancy terminations) with TOF (cases) relative to the odds of a birth with one of the malformed controls (club-foot, angioma, skin
abnormality, polydactyly, syndactyly, and congenital hip dislocation).
§Adjustment was made for maternal age, occupation, geographic origin, paternal age and year of birth.
$Inductors of ovulation.
£In vitro fertilization.
¥IVF with intracytoplasmic sperm injection.
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risk of birth defects. However, the strategy of “adjusting
for infertility” (time to pregnancy or duration of infertility)
has been criticized [5] as it could be “synonymous” with
exposure to ART. In any case, in our data, essentially all
women who had a duration of infertility of more than two
years had conceived following ART; adjustment for infer-
tility duration was therefore not feasible in our study.
The frequency of missing data was low for exposure to
ART and maternal characteristics. However, paternal age
was missing for 25% of the study population. We adjusted
for paternal age as it can be related to ART exposure and
particularly ICSI. Results were nevertheless similar when
models did not include paternal age and in analyses that
included multiple imputation for paternal age (results not
shown, available from authors).
Conclusion
In conclusion, we found that most of the higher risk of
TOF associated with ART is a “direct” effect (i.e. not medi-
ated by multiple pregnancies) and only a small proportion
of the effect may be due to multiple pregnancies. This was
particularly the case for IVF + ICSI and may provide clues
about the possible underlying mechanism(s) for the associ-
ation between ART and TOF. The path-analysis approach
presented here may be more generally useful for assessing
the role of multiple pregnancies in the association between
ART and risk of other congenital malformations or other
adverse outcomes.
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